From professional translators, enterprises, web pages and freely available translation repositories.
carcinogenicitetsforsøg er ikke udført.
no carcinogenicity studies have been performed.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
der er ikke udført carcinogenicitetsforsøg med telithromycin.
no carcinogenicity studies have been conducted with telithromycin.
Last Update: 2012-04-11
Usage Frequency: 3
Quality:
der er ikke udført nogen carcinogenicitetsforsøg med cabazitaxel.
carcinogenicity studies have not been conducted with cabazitaxel.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
i carcinogenicitetsforsøg med mus viste en stigning i lymfomer og mammatumorer.
in carcinogenicity studies in mice, an increase in lymphomas and mammary tumours were noted.
Last Update: 2017-04-26
Usage Frequency: 4
Quality:
i et carcinogenicitetsforsøg på rotter udviste leflunomid ingen carcinogene egenskaber.
in a carcinogenicity study in rats, leflunomide did not show carcinogenic potential.
Last Update: 2017-04-26
Usage Frequency: 6
Quality:
ret vivo og in-vitro.der er ikke udført carcinogenicitetsforsøg med telithromycin.
no carcinogenicity studies have been conducted with telithromycin.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
i et carcinogenicitetsforsøg udviklede hanrotter leydig celle- tumorer og - hyperplasi.
in a carcinogenicity study, male rats developed leydig cell tumours and hyperplasia.
Last Update: 2012-04-12
Usage Frequency: 7
Quality:
i carcinogenicitetsforsøg med mus blev der udviklet dosisrelateret gastrisk hyperplasi i ecl- celler samt levertumorer og adenom i rete testis.
in mouse carcinogenicity studies dose-related gastric ecl cell hyperplasia developed as well as liver tumours and adenoma of rete testis.
Last Update: 2012-04-12
Usage Frequency: 5
Quality:
der er i et carcinogenicitetsforsøg med mus set en øget incidens i forekomsten af maligne lymfomer og mammatumorer (hos hunmus).
in a mouse carcinogenicity study, increases in the incidence of malignant lymphomas and mammary tumours (in females) occurred.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
i et 24- måneders intramuskulært carcinogenicitetsforsøg med rotter blev der ikke observeret stigning i incidensen af tumorer på injektionsstedet i hverken vehikelgruppen eller de aktive grupper.
there was no increased incidence of mortality among patients taking other diuretics as concomitant treatment with risperidone.
Last Update: 2012-04-12
Usage Frequency: 2
Quality:
i et carcinogenicitetsforsøg på mus sås øget forekomst af malignt lymfom hos hanner i den gruppe, der fik højeste dosis, hvilket anses at skyldes leflunomids immunsupprimerende aktivitet.
in a carcinogenicity study in mice an increased incidence of malignant lymphoma occurred in males of the highest dose group, considered to be due to the immunosuppressive activity of leflunomide.
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
i to carcinogenicitetsforsøg med rotter fremkaldte lansoprazol dosisrelateret gastrisk ecl - cellehyperplasi og ecl- cellecarcinoider, der blev forbundet med hypergastrinæmi på grund af hæmningen af syresekretion.
in two rat carcinogenicity studies, lansoprazole produced dose-related gastric ecl cell hyperplasia and ecl cell carcinoids associated with hypergastrinaemia due to inhibition of acid secretion.
Last Update: 2012-04-12
Usage Frequency: 5
Quality:
resultaterne fra et carcinogenicitetsforsøg med mus vil normalt ikke betragtes som negativt, med mindre der er en overlevelse på 75 til 80% i hver afprøvningsgruppe 18 måneder efter starten af doseringen.en lignende overlevelsesrate bør forventes for rotter efter 2 år.
the results of a carcinogenicity test in mice would not normally be regarded as negative uniese there was a 79$ to 80$ survival of the animals in each test group for 18 months from the start of dosing. a similar survival rate over 2 years should be expected in rats.
Last Update: 2014-02-06
Usage Frequency: 1
Quality:
i et intramuskulært carcinogenicitetsforsøg med risperdal consta hos wistar- rotter (hannover) (doser på 5 og 40 mg/ kg/ 2 uger) blev der observeret øget incidens af tumorer i endokrin pankreas, hypofyse og binyremarv ved 40 mg/ kg, mens brystkirteltumorer blev observeret ved både 5 and 40 mg/ kg.
elderly patients with dementia risperdal consta has not been studied in elderly patients with dementia, hence it is not indicated for use in this group of patients.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.